Related Experiment Video
Updated: Apr 5, 2026
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing
Hongxiang Feng1, Xiaowei Wang1, Zhenrong Zhang1
1Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.
Abstract:
Lung cancer remains the most prevalent malignancy and the primary cause of cancer-related deaths worldwide. Unique mutations patterns can be found in lung cancer subtypes, in individual cancers, or within a single tumor, and drugs that target these genetic mutations and signal transduction pathways are often beneficial to patients. In this study, we used the Ion Torrent AmpliSeq Cancer Panel to sequence 737 loci from 45 cancer-related genes and oncogenes to identify genetic mutations in 48 formalin-fixed, paraffin-embedded (FFPE) human lung cancer samples from Chinese patients. We found frequent mutations in EGFR, KRAS, PIK3CA, and TP53 genes. Moreover, we observed that a portion of the lung cancer samples harbored two or more mutations in these key genes. This study demonstrates the feasibility of using the Ion Torrent sequencing to efficiently identify genetic mutations in individual tumors for targeted lung cancer therapy.
Insights
This study identified frequent genetic mutations in key genes like EGFR and TP53 in Chinese lung cancer patients. Ion Torrent sequencing efficiently detects these mutations for personalized, targeted lung cancer therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Lung cancer is a leading cause of cancer deaths globally.
- Tumor genetic mutations drive cancer development and response to therapy.
- Targeted therapies offer improved outcomes for patients with specific mutations.
Purpose of the Study:
- To identify common genetic mutations in lung cancer samples from Chinese patients.
- To evaluate the utility of Ion Torrent sequencing for mutation detection.
- To inform targeted therapy strategies for lung cancer.
Main Methods:
- Sequencing of 737 loci across 45 cancer-related genes using the Ion Torrent AmpliSeq Cancer Panel.
- Analysis of 48 formalin-fixed, paraffin-embedded (FFPE) human lung cancer samples.
- Identification of genetic mutations in key oncogenes and tumor suppressor genes.
Main Results:
- Frequent mutations were observed in EGFR, KRAS, PIK3CA, and TP53 genes.
- Multiple mutations within these key genes were detected in a subset of samples.
- Ion Torrent sequencing proved effective for mutation profiling.
Conclusions:
- The study confirms the presence of actionable mutations in Chinese lung cancer patients.
- Ion Torrent sequencing is a feasible and efficient method for identifying tumor-specific mutations.
- Findings support the use of targeted therapies based on individual tumor genetic profiles.
